HTGM - HTG Molecular Diagnostics Inc. (HTGM) CEO John Lubniewski on Q4 2021 Results - Earnings Call Transcript
HTG Molecular Diagnostics, Inc. (HTGM) Q4 2021 Earnings Conference Call March 29, 2022 16:30 ET Corporate Participants Andrew Eriksen - IR, LifeSci Advisors John Lubniewski - Chief Executive Officer Shaun McMeans - Chief Financial Officer Conference Call Participants Rick Krause - Cantor Fitzgerald Alex Nowak - Craig-Hallum Capital Group Presentation Operator Welcome to the HTG Molecular Diagnostics, Inc. Fourth Quarter 2021 Earnings Conference Call. As a reminder, all participants are in a listen-only mode and the conference is being recorded. After the presentation there will be an opportunity to ask questions. [Operator Instructions]. I would now like to turn the conference over to Andrew Eriksen from LifeSci Advisors. Please go ahead. Andrew Eriksen Before we begin the call, let me remind you that the company's remarks include forward-looking statements within the meaning of the federal securities laws including statements regarding our expected revenue recovery, the importance of company’s HTG transcriptome
For further details see:
HTG Molecular Diagnostics, Inc. (HTGM) CEO John Lubniewski on Q4 2021 Results - Earnings Call Transcript